Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHSE: 605199)
Health Care · Pharmaceuticals · CN
CN¥5.71
-0.87% today · -35.2% 1Y
Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHSE: 605199) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $340.59M and employs 2,103 people.
Over the last twelve months the share price has lost 35.2%, trading between 5.15 and 10.37.
Tweenvest scores Hainan Huluwa Pharmaceutical Group Co., Ltd. across four factors: quality 50/100, value 64/100, growth 0/100. Its strongest factor is value.
605199 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $340.59M
- Revenue (TTM)
- $93.34M
- P/E
- —
- EPS
- -0.84
- Dividend yield
- —
- Beta (5Y)
- 0.34
- 52-week high
- CN¥10.37
- 52-week low
- CN¥5.15
- Avg volume (3M)
- —
- Shares outstanding
- 400.11M
- Employees
- 2,103
- Next earnings
- —
About Hainan Huluwa Pharmaceutical Group Co., Ltd.
Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other fields in China. The company offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. Hainan Huluwa Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Haikou, China.
- ISIN
- CNE100004223
- Founded
- 2005
- Listed since
- Jul 10, 2020
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jilin Jian Yisheng Pharmaceutical Co., Ltd.SZSE: 002566 | $348.33M | CN¥7.06 | +1.44% |
| Boiron SAENXTPA: BOI | $344.13M | €17.70 | -3.28% |
| Hanshang Group Co., Ltd.SHSE: 600774 | $343.39M | CN¥7.97 | +3.51% |
| Swedencare AB (publ)OM: SECARE | $342.00M | Skr21.40 | +0.23% |
| Ildong Pharmaceutical Co., Ltd.KOSE: A249420 | $339.47M | ₩14,510.00 | +4.84% |
| Hubei Guangji Pharmaceutical Co., Ltd.SZSE: 000952 | $336.93M | CN¥6.57 | +1.39% |
| Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.SHSE: 603168 | $336.88M | CN¥6.04 | +3.25% |
| Enwei Pharmaceutical Co., Ltd.SZSE: 301331 | $331.70M | CN¥21.84 | +1.06% |
Figures last refreshed Oct 4, 2026.